These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38228284)

  • 41. Personalized integrative oncology: targeted approaches for optimal outcomes: the 11th International Conference of the Society for Integrative Oncology.
    Lee RT; Yang P; Greenlee H; Bauer-Wu S; Balneaves LG; Zick S
    Integr Cancer Ther; 2015 Jan; 14(1):98-105. PubMed ID: 25505022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncology in 2012: from personalized medicine to precision medicine.
    Morere JF
    Target Oncol; 2012 Dec; 7(4):211-2. PubMed ID: 23179557
    [No Abstract]   [Full Text] [Related]  

  • 43. [Implementing next-generation sequencing for precision hematology/oncology].
    Maeda T
    Rinsho Ketsueki; 2018; 59(10):1924-1934. PubMed ID: 30305493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Precision medicine in oncology: what is it exactly and where are we?
    Le Tourneau C; Kamal M; Bièche I
    Per Med; 2018 Sep; 15(5):351-353. PubMed ID: 30260312
    [No Abstract]   [Full Text] [Related]  

  • 45. Ophthalmic oncology: errors and shibboleths the 1997 dohlman lecture.
    Char DH
    Int Ophthalmol Clin; 1997; 37(4):1-24. PubMed ID: 9429929
    [No Abstract]   [Full Text] [Related]  

  • 46. [The breakthrough of personalized medicine, new hopes and new challenges].
    Flippot R; Massard C; Auclin E; Azria D; Bourien H; Rochigneux P; Schernberg A; Verlingue L; Zafrani L; Vignot S
    Bull Cancer; 2017 Sep; 104(9):735-743. PubMed ID: 28807365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding the Precision in "Precision Medicine".
    Chabner BA
    Oncologist; 2016 Sep; 21(9):1029-30. PubMed ID: 27566249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
    Golan T; Milella M; Ackerstein A; Berger R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Standing in the Shifting Sands of Molecular Targeting and Precision Medicine Is the Oasis of 21st-Century Oncology Therapeutics.
    Lee L; Lewis LD
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S7-S10. PubMed ID: 28921639
    [No Abstract]   [Full Text] [Related]  

  • 50. Optical coherence tomography imaging of ocular and periocular tumours.
    Medina CA; Plesec T; Singh AD
    Br J Ophthalmol; 2014 Jul; 98 Suppl 2(Suppl 2):ii40-6. PubMed ID: 24599420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer prevention in the era of precision oncology.
    Brahme NN; Szabo E
    Clin Pharmacol Ther; 2017 May; 101(5):575-577. PubMed ID: 28032900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Precision oncology and molecular tumor boards].
    Mack E; Horak P; Fröhling S; Neubauer A
    Inn Med (Heidelb); 2024 May; 65(5):462-471. PubMed ID: 38652307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Public health strategy vs. golden standard for ocular cancer care in Brazil.
    Belfort Neto R
    Arq Bras Oftalmol; 2020; 83(1):V-VI. PubMed ID: 32130305
    [No Abstract]   [Full Text] [Related]  

  • 54. Do you speak ocular tumor?
    Finger PT
    Ophthalmology; 2003 Jan; 110(1):13-4. PubMed ID: 12511339
    [No Abstract]   [Full Text] [Related]  

  • 55. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
    Walko C; Kiel PJ; Kolesar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Precision Oncology: Approaching the Target].
    Hiddemann W
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1637. PubMed ID: 29078208
    [No Abstract]   [Full Text] [Related]  

  • 57. Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.
    Tamborero D; Dienstmann R; Rachid MH; Boekel J; Baird R; Braña I; De Petris L; Yachnin J; Massard C; Opdam FL; Schlenk R; Vernieri C; Garralda E; Masucci M; Villalobos X; Chavarria E; ; Calvo F; Fröhling S; Eggermont A; Apolone G; Voest EE; Caldas C; Tabernero J; Ernberg I; Rodon J; Lehtiö J
    Nat Med; 2020 Jul; 26(7):992-994. PubMed ID: 32632195
    [No Abstract]   [Full Text] [Related]  

  • 58. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Precision oncology in non-small-cell lung cancer: opportunities and challenges.
    Kim C; Giaccone G
    Nat Rev Clin Oncol; 2018 Jun; 15(6):348-349. PubMed ID: 29599475
    [No Abstract]   [Full Text] [Related]  

  • 60. [The eye and cancer].
    Schalenbourg A; Mantel I
    Rev Med Suisse; 2015 Dec; 11(499):2395-8. PubMed ID: 26852556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.